Molecular epidemiology of Burkholderia species

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Coenye, Tom ^a   LiPuma, John J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

B. cepacia; Burkholderia; Cystic fibrosis; Epidemiology; Genotyping; Review

Indexed keywords

ARTICLE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA GLADIOLI; BURKHOLDERIA PSEUDOMALLEI; CYSTIC FIBROSIS; EPIDEMIOLOGICAL DATA; HUMAN; INFECTION CONTROL; NONHUMAN; STRAIN DIFFERENCE; TAXONOMY;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA GLADIOLI; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI;

EID: 3142718330     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Article

References (176)

1. Coenye T., P. Vandamme, J. R. W. Govan & J .J. LiPuma: Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39, 3427-3436 (2001)
2. Srinivasan A., C. N. Kraus, D. DeShazer, P. M. Becker, J. D. Dick, L. Spacek, J. G. Bartlett, W. R. Byrne & D. L. Thomas: Glanders in a military research microbiologist. N Engl J Med 345, 256-258 (2001)
3. Chaowagul W., N. J. White, D. A. Dance, Y. Wattanagoon, P. Naigowit, T. M. Davis, S. Looareesuwan & N. Pitakwatchara: Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 159, 890-899 (1989)
4. Govan J.R.W., J. E. Hughes & P. Vandamme: Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 45, 395-407 (1996)
5. LiPuma J. J.: Burkholderia cepacia: management issues and new insights. Clin Chest Med 19, 473-486 (1998)
6. LiPuma J. J.: Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Op Pulm Med 4, 337-341 (1998)
7. LiPuma J. J. & E. Mahenthiralingam: Commercial use of Burkholderia cepacia. Emerg Infect Dis 5, 305-306 (1999)
8. Holmes A., J. Govan, R. Goldstein: Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis 4, 221-227 (1998)
9. Govan J.R.W. & V. Deretic: Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60, 539-574 (1996)
10. Jones A. M., M. E. Dodd & A. K. Webb: Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J 17, 295-301 (2001)
11. Mohr C. D., M. Tomich & C. A. Herfst: Cellular aspects of Burkholderia cepacia infection. Microbes Infect 3, 425-435 (2001)
12. Hancock R. E.: Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 27, S93-S99 (1998)
13. Parke J. L. & D. Gurian-Sherman: Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. Annu Rev Phytopathol 39, 225-258 (2001)
14. Burkholder W. H.: Sour skin, a bacterial rot of onion bulbs. Phytopathol 40, 115-117 (1950)
15. Kersters K., W. Ludwig, M. Vancanneyt, P. De Vos, M. Gillis & K. H. Schleifer: Recent changes in the classification of the pseudomonads: an overview. Syst Appl Microbiol 19, 465-477 (1996)
16. Palleroni N. J., R. Kunisawa, R. Contopolous & M. Doudoroff: Nucleic acid homologies in the genus Pseudomonas. Int J Syst Bact 23, 333-339 (1973)
17. De Vos P., M. Goor, M. Gillis & J. De Ley: Ribsomal ribonucleic acid cistron similarities of phytopathogenic Pseudomonas species. Int J Syst Bact 35, 169-184 (1985)
18. Yabuuchi E., Y. Kosako, H. Oyaizu, I. Yano, H. Hotta, Y. Hashimoto, T. Ezaki & M. Arakawa: Proposal of Burkholderia gen. nov.; and transfer of seven species of the Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 39, 897-904 (1992)
19. De Ley J.: The Proteobacteria: ribosomal RNA cistron similarities and bacterial taxonomy. In: The Prokaryotes, 2nd edition. Eds: Balows A, Truper H, Dworkin M, Harder W, Schleifer KH, Springer-Verlag, NY (1992)
20. Woese C. R.: Bacterial evolution. Microbiol Rev 51, 221-271 (1987)
21. Vandamme P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters & J. R. W. Govan: Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bact 47, 1188-1200 (1997)
22. Vandamme P., E. Mahenthiralingam, B. Holmes, T. Coenye, B. Hoste, P. De Vos, D. Henry & D. P. Speert: Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J Clin Microbiol 38, 1042-1047 (2000)
23. Coenye T., J. J. LiPuma, D. Henry, B. Hoste, K. Vandemeulebroecke, M. Gillis, D. P. Speert & P. Vandamme: Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol 51, 271-279 (2001)
24. Coenye T., E. Mahenthiralingam, D. Henry, J. J. LiPuma, S. Laevens, M. Gillis, D. P. Speert & P. Vandamme: Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol 51, 1481-1490 (2001)
25. Vandamme P., D. Henry, T. Coenye, S. Nzula, M. Vancanneyt, J. J. LiPuma, D. P. Speert, J. R. W. Govan & E. Mahenthiralingam: Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound test results of new molecular diagnostic tools. FEMS Immunol Med Microbiol 33, 143-149 (2002)
26. Rabkin C. S., W. R. Jarvis & W. J. Martone: Current status of Pseudomonas cepacia typing systems. Eur J Epidemiol 3, 343-346 (1987)
27. Rabkin C. S., W. R. Jarvis, R. L. Anderson, J. Govan, J. Klinger, J. J. LiPuma, W. J. Martone, H. Monteil, C. Richard, S. Shigeta, A. Sosa, T. Stull, J. Swenson & D. Woods: Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis 11, 600-607 (1989)
28. Arbeit R. D.: Laboratory procedures for the epidemiologic analysis of microorganisms. In: Manual of clinical microbiology. 6th edition. Eds: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, ASM Press, Washington DC, (1995)
29. LiPuma J. J.: Molecular tools for epidemiological study of infectious diseases. Pediatr Infect Dis J 17, 667-675 (1998)
30. Olive D. M & P. Bean: Principles and applications of methods for DNA-based typing of microbial organisms. J Clin Microbiol 37, 1661-1669 (1999)
31. Stull T. L., J. J.LiPuma & T. D. Edlind: A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J Infect Disease 157, 280-286 (1988)
32. Bingen E. H., E. Denamur & J. Elion: Use of ribotyping in epidemiological surveillance of nosocomial outbreaks. Clin Microbiol Rev 7, 311-327 (1994)
33. Kostman J. R., M. B. Alden, M. Mair, T. D. Edlind, J. J. LiPuma & T. L. Stull: A universal approach to bacterial molecular epidemiology by polymerase chain reaction ribotyping. J Infect Dis 171, 204-208 (1995)
34. LiPuma J. J., J. E. Mortensen, S. E. Dasen, T. D. Edlind, D. V. Schidlow, J. L. Burns & T. L. Stull: Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr 113, 859-862 (1988)
35. LiPuma J. J., S. E. Dasen, D. W. Nielson, R. C. Stern & T. L. Stull: Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336, 1094-1096 (1990)
36. LiPuma, J. J., K. A. Marks-Austin, D. S. Holsclaw, G. B. Winnie, P. H. Gilligan & T. L. Stull: Inappararent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J 13, 716-719 (1994)
37. Dasen S. E., J. J. LiPuma, J. R. Kostman & T. L. Stull: Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia. J Clin Microbiol 32, 2422-2424 (1994)
38. Tenover F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing & B. Swaminathan: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239 (1995)
39. van Belkum A.: DNA fingerprinting of medically important microorganisms by use of PCR. Clin Microbiol Rev 7, 174-184 (1994)
40. Power E. G.: RAPD typing in microbiology - a technical review. J Hosp Infect 34, 247-265 (1996)
41. Maiden M. C. J., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q. Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman & B. G. Spratt: Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 95, 3140-3145 (1998)
42. Enright M. C. & B. G. Spratt: Multilocus sequence typing. Trends Microbiol 7, 482-487 (1999)
43. Musser J. M.: Molecular population genetic analysis of emerged bacterial pathogens: selected insights. Emerg Infect Dis 2, 1-17 (1996)
44. McArthur J. V., D. A. Kovacic & M. H. Smith: Genetic diversity in natural populations of a soil bacterium across a landscape gradient. Proc Natl Acad Sci USA 85, 9621-9624 (1988)
45. Johnson W. M., S. D. Tyler & K. R. Rozee: Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol 32, 924-930 (1994)
46. Wise M. G., L. J. Shimkets & J. V. McArthur: Genetic structure of a lotic population of Burkholderia (Pseudomonas) cepacia. Appl Env Microbiol 61, 1791-1798 (1995)
47. Wise M. G., J. V. McArthur, C. Wheat & L. J. Shimkets: Temporal variation in genetic diversity and structure of a lotie population of Burkholderia (Pseudomonas) cepacia. Appl Env Microbiol 62, 1558-1562 (1996)
48. Coenye T. & J. J. LiPuma: Multilocus restriction typing, a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis. J Infect Dis 185:1454-1462 (2002)
49. Coenye T., T. Spilker, A. Martin, J. J. LiPuma: Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol (in press)
50. Mahenthiralingham E., M. E. Campbell, D. A. Henry & D. P. Speert: Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol 34, 2914-2920 (1996)
51. Bingen E. H., M. Weber, J. Derelle, N. Brahimi, N. Y. Lambert-Zechovsky, M. Vidailhet, J. Navarro & J. Elion: Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol 31, 2589-2593 (1993)
52. Liu P. Y., Z. Y. Shi, Y. J. Lau, B. S. Hu, J. M. Shyr, W. S. Tsai, Y. H. Lin & C. Y. Tseng: Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates. J Clin Microbiol 33, 3304-3307 (1995)
53. Zeitlin, P. L.: Novel pharmacologic therapies for cystic fibrosis. J Clin Invest 103, 447-452 (1999)
54. Larson J. E. & J. C. Cohen: Cystic fibrosis revisited. Mol Genet Metabol 71, 470-477 (2000)
55. Dinwiddie R.: Pathogenesis of lung diseases in cystic fibrosis. Respiration 67, 3-8 (2000)
56. Lewin L. O., P. J. Byard & P. B. Davis: Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 43, 125-131 (1990)
57. Corey M. & V. Farewell: Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 143, 1007-1017 (1996)
58. Muhdi K., F. P. Edenborough, L. Gumery, S. O'Hickey, E. G. Smith, D. L. Smith & D. E. Stableforth: Outcome for patients colonized with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax 51, 374-377 (1996)
59. Liou T. G., F. R. Adler, S. C. FitzSimmons, B. C. Cahill, J. R. Hibbs & B. C. Marshall: Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemol 153, 345-352 (2001)
60. McCloskey M., J. McCaughan, A. O. B. Redmond & J. S. Elborn: Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis. Ir J Med Sci 170, 28-31 (2001)
61. Ledson M. J., M. J. Gallagher, M. Jackson, C. A. Hart & M. J. Walshaw: Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 57, 142-145 (2002)
62. LiPuma J. J.: Burkholderia cepacia complex: A contraindication to lung transplantation in CF? Transpl Infec Dis 3, 150-161 (2001)
63. Blessing J., J. Walker, B. Maybury: Pseudomonas cepacia and maltophilia in the cystic fibrosis patient. Am Rev Respir Dis Suppl 119, 262 (1979)
64. Laraya-Cuasay L. R., M. Lipstein, N. N. Huang: Pseudomonas cepacia in the respiratory flora of patients with cystic fibrosis. Pediatr Pulmonol 11, 502 (1977)
65. Rosenstein B. J. & D. E. Hall: Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis. Johns Hopkins Med J 147, 188-189 (1980)
66. Nolan G., P. Moivor, H. Levison, P. C. Fleming, M. Corey & R.Gold: Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin. J Pediatr 101, 626-630 (1982)
67. Gold R., E. Jin, H. Levison, A. Isles & P. C. Fleming: Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother 12 Suppl A, 331-336 (1983)
68. Isles A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming & H. Levison: Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104, 206-210 (1984)
69. Thomassen M. J., C. A. Demko, J. D. Klinger & R. C. Stern: Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis 131, 791-796 (1985)
70. Tablan O. C., T. L. Chorda, D. V. Schidlow, J. W. White, K. A. Hardy, P. H. Gilligan, W. M. Morgan, L. A. Carson, W. J. Martone & J. M. Jason: Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 107, 382-387 (1985)
71. Tablan O. C., W. J. Martone, C. F. Doerschuk, R. C. Stern, M. J. Thomassen, J. D. Klinger, J. W. White, L. A. Carson & W. R. Jarvis: Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest 91, 527-532 (1987)
72. Thomassen M. J., C. A. Demko, C. F. Doerschuk, R. C. Stern & J. D. Klinger: Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis 134, 669-671 (1986)
73. Millar-Jones L., A. Paull, Z. Saunders & M. C. Goodchild: Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet 340, 491 (1992)
74. Smith D. L., L. B. Gummery, E. G. Smith, D. E. Stableforth, M. E. Kaufmann & T. L. Pitt: Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol 31, 3017-3022 (1993)
75. Govan J. R. W., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening & A. K. Webb: Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis patients. Lancet 342, 15-19 (1993)
76. John M., E. Ecclestone, E. Hunter, P. Couroux & Z. Hussain: Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis. Pediatr Pulmon 18, 108-113 (1994)
77. Pegues D. A., L. A. Carson, O. C. Tablan, S. C. FitzSimmons, S. B. Roman, J. M. Miller & W. R. Jarvis: Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J Pediatr 124, 694-702 (1994)
78. Whiteford M. L., J. D. Wilkinson, J. H. McColl, F. M. Conlon, J. R. Michie, T. J. Evans & J. Y. Paton: Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 50, 1194-1198 (1995)
79. Hardy A. K., K. L. McGowan, M. C. Fisher & D. V. Schidlow: Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients. J Pediatr 109, 51-54 (1986)
80. Taylor C. J., R. Howden, T. Smith & R. C. Spencer: Pseudomonas cepacia. Arch Dis Child 70, 358 (1994)
81. Ryley H. C., B. Ojeniyi, N. Hoiby & J. Weeks: Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 15, 755-758 (1996)
82. Pegues D. A., D. V. Schidlow, O. C. Tablan, L. A. Carson, N. C. Clark & W. R. Jarvis: Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis. Arch Ped Adolesc Med 148, 805-812 (1994)
83. Drabick J. A., E. J. Gracely, G. J. Heidecker & J. J. LiPuma: Survival of Burkholderia cepacia on environmental surfaces. J Hosp Infect 32, 267-276 (1996)
84. Hymphreys H., D. Peckham, P. Patel & A. Knox: Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis. Thorax 49, 1157-1159 (1994)
85. Ensor E., H. Humphreys, D. Peckham, C. Webster & A. J. Knox: Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy? J Hosp Infect 32, 9-15 (1996)
86. Pitchford K. C., M. Corey, A. K. Highsmith, R. Perlman, R. Bannatyme, R. Gold, H. Levinson, E. L. Ford-Jones: Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment. J Pediatr 111, 212-216 (1987)
87. Burgde D. R., E. M. Nakielna & M. A. Noble: Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 14, 127-130 (1993)
88. Hutchinson G. R., S. Parker, J. A. Pryor, F. Duncan-Skingle, P. N. Hoffman, M. E. Hodson, M. E. Kaufmann & T. L. Pitt: Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol 34, 584-587 (1996)
89. Doring G., S. Jansen, H. Noll, H. Grupp, F. Frank, K. Botzenhart, K. Magdorf & U. Wahn: Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Pediatr Pulmon 21, 90-100 (1996)
90. Moore J. E., I. Thompson, M. Crowe, J. Xu, A. Shaw, B. C. Millar, A. O. B. Redmond, A. J. M. Reid, C. Clarke & J. S. Elborn: Burkholderia cepacia from a sink drain. J Hosp Infect 50, 235-237 (2002)
91. Dy M. E., J. A. Nord, V. LaBombardi, J. Germana & P. Walker: Lack of throat colonization with Burkholderia cepacia among cystic fibrosis healthcare workers. Infect Control Hosp Epidemiol 20, 90 (1999)
92. Fisher M. C., J. J. LiPuma, S. E. Dasen, G. C. Caputo, J. E. Mortensen, K. L. McGowan & T. L. Stull: Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. J Pediatr 123, 745-747 (1993)
93. Mortensen J. E., M. C. Fisher & J. J. LiPuma: Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol 16, 30-32 (1995)
94. Butler S. L., C. J. Doherty, J. E. Hughes, J. W. Nelson & J. R. W. Govan: Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol 33, 1001-1004 (1995)
95. Gonzalez C. F., G. L. Mark, E. Mahenthiralingam & J. J. LiPuma: Isolation of soilborne genomovar III Burkholderia cepacia and lytic phages with intergenomovar host range. Pediatr Pulmonol S20, 288-289 (2000)
96. Balandreau J., V. Viallard, B. Cournoyer, T. Coenye, S. Laevens & P. Vandamme: Burkholderia cepacia genomovar III is a common plant-associated bacterium. Appl Env Microbiol 67, 982-985 (2001)
97. Fiore A., S. Laevens, A. Bevivino, C. Dalmastri, S. Tabbacchioni, P. Vandamme & L. Chiarini: Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy. Environ Microbiol 3, 137-143 (2001)
98. Bevivino A., C. Dalmastri, S. Tabacchioni, L. Chiarini, M. L. Belli, S. Piana, A. Materazzo, P. Vandamme & G. Manno: Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 40, 846-851 (2002)
99. LiPuma J. J., T. Spilker, T. Coenye & C. F. Gonzalez: An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 359, 2002-2003 (2002)
100. Miller S. M., J. L. Parke, S. Bies & J. J. LiPuma: Detection, recovery and identification of Burkholderia cepacia from the natural environment. Pediatr Pulmonol S20, 288 (2000)
101. Moore J. E., B. McIlhatton, A. Shaw, P. G. Murphy & J. S. Elborn: Occurrence of Burkholderia cepacia in foods and waters: clinical implications for patients with cystic fibrosis. J Food Prot 7, 1076-1078 (2001)
102. Berriatua E., I. Ziluaga, C. Miguel-Virto, P. Uribarren, R. Juste, S. Laevens, P. Vandamme & J. R. W. Govan: Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J Clin Microbiol 39, 990-994 (2001)
103. LiPuma J. J., T. Spilker, L. H. Gill, P. W. Campbell III, L. Liu & E. Mahenthiralingam: Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 164, 92-96 (2001)
104. Agodi A., E. Mahenthiralingam, M. Bachitta, V. Giannino, A. Sciacca & S. Stefani: Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol 39, 2891-2896 (2001)
105. Speert D. P., D. Henry, P. Vandamme, M. Corey & E. Mahenthiralingam: Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 8, 181-187 (2002)
106. Pitt T. L., M. E. Kaufmann, P. S. Patel, L. C. Benge, S. Gaskin & D. M. Livermore: Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 44, 203-210 (1996)
107. Sun L., R. Z. Jiang, S. Steinbach, A. Holmes, C. Campanelli, J. Forstner, U. Sajjan, Y. Tan, M. Riley & R. Goldstein: The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in north America and Britain. Nat Med 1, 661-666 (1995)
108. Kumar A., S. Dietrich, W. Schneider, R. Jacobson, F. Pouch Downes, B. E. Robinson-Dunn, R. Honicky, J. Smith & R. Martin: Genetic relatedness of Burkholderia (Pseudomonas) cepacia isolates from five cystic fibrosis centers in Michigan. Resp Med 91, 485-492 (1997)
109. Mahenthiralingam E., D. A. Simpson & D. P. Speert: Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 35, 808-816 (1997)
110. Simpson I. N., J. Finlay, D. J. Winstanley, N. Dewhurst, J. W. Nelson, S. L. Butler & J. R. W. Govan: Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antmicrob Chemother 34, 353-361 (1994)
111. Chen J., K. A. Witzmann, T. Spilker, R. J. Fink & J. J. LiPuma: Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 139, 643-649 (2001)
112. Segonds C., T. Heulin, N. Marty & G. Chabanon: Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J Clin Microbiol 37, 2201-2208 (1999)
113. Whitby P. W., H. L. N. Dick, P. W. Campbell III, D. E. Tullis, A. Matlow & T. L. Stull: Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis. J Clin Microbiol 36, 1642-1645 (1998)
114. Mahenthiralingam E., P. Vandamme, M. E. Campbell, D. A. Henry, A. M. Gravelle, L. T. K. Wong, A. G. F. Davidson, P. G. Wilcox, B. Nakielna & D. P. Speert: Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 33, 1469-1475 (2001)
115. Ledson M. J., M. J. Gallagher, J. E. Corkill, C. A. Hart & M. J. Walshaw: Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 53, 432-436 (1998)
116. Hearst J. E. & K. E. Elliott: Identifying the killer in cystic fibrosis. Nat Med 1, 626-627 (1995)
117. Clode F. E., M. E. Kaufmann, H. Malnick & T. L. Pitt: Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol 38, 1763-1766 (2000)
118. Mahenthiralingam E., T. Coenye, J. W. Chung, D. P. Speert, J. R. Govan, P. Taylor & P. Vandamme: Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38, 910-913 (2000)
119. Aris R. M., J. C. Routh, J. J. LiPuma, D. G. Heath & P. H. Gilligan: Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: survival linked to genomovar type. Am J Respir Crit Care Med 164, 2102-2106 (2001)
120. De Soyza A., A. McDowell, L. Archer, J. H. Dark, S. J. Elborn, E. Mahenthiralingam, K. Gould & P. A. Corris: Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358, 1780-1781 (2001)
121. Bottone E. J., S. D. Douglas, A. R. Rausen & G. T. Keusch: Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol 1, 425-428 (1975)
122. Siber O. F. & V. A. Fulginiti: Pseudomonas cepacia pneumonia in a child with chronic granulomatous disease and selective IgA deficiency. Acta Paediatr Scand 65, 519-520 (1976)
123. Lacy D. E., D. A. Spencer, A. Goldstein, P. H. Weller & P. Darbyshire: Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia. J Infect 27, 301-304 (1993)
124. Ahlin A., M. De Boer, D. Roos, J. Leusen, C. I. Smith, U. Sundin, H. Rabbani, J. Palmblad & G. Blinder: Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 84, 1386-1394 (1995)
125. Johnston R. B.: Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 8, 17-22 (2001)
126. Winkelstein J. A., M. C. Marino, R. B. Johnston, J. Boyle, J. Curnutte, J. I. Gallin, H. L. Malech, S. M. Holland, H. Ochs, P. Quie, R. H. Buckley, C. B. Foster, S. J. Chanock & H. Dickler: Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 79, 155-169 (2000)
127. Speert D. P., M. Bond, R. C. Woodman & J. T. Curnutte: Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J Infect Dis 170, 1524-1531 (1994)
128. Pegues D. A., L. A. Carson, R. L. Anderson, M. J. Norgard, T. A. Argent, W. R. Jarvis & C. H. Woernle: Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis 16, 407-411 (1993)
129. Yamagishi Y., J. Fujita, K. Takigawa, K. Negayama, T. Nakazawa & J. Takahara: Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest 103, 1706-1709 (1993)
130. van Laer F., D. Raes, P. Vandamme, C. Lammens, J. P. Sion, C. Vrints, J. Snoeck & H. Goossens: An outbreak of Burkholderia cepacia with septicaemia on a cardiology ward. Infect Control Hosp Epidemiol 19, 112-113 (1998)
131. Kaitwatcharachai C., K. Silpapojakul, S. Jitsurong & S. Kalnauwakul: An outbreak of Burkholderia cepacia bacteremia in hemodialysis patients: an epidemiological and molecular study. Am J Kidney Dis 36, 199-204 (2000)
132. Mandell I. N., H. D. Feiner, N. M. Price & M. Simberkoff: Pseudomonas cepacia endocarditis and ecthyma gangrenosum. Arch Dermatol 113, 199-202 (1977)
133. Hobson R., I. Gould & J. Govan: Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media. Eur J Clin Microbiol Infect Dis 14, 908-911 (1995)
134. Waterer G. W., C. B. Jones & R. G. Wunderink: Bacteremic community-acquired pneumonia in an immunocompetent adult due to Burkholderia cepacia. Chest 116, 1842-1843 (1999)
135. Steere A. C., J. H. Tenney, D. C. Mackel, M. J. Snyder, S. Polakavetz, M. E. Dunne & R. Dixon: Pseudomonas species bacteremia caused by contaminated normal human serum albumin. J Infect Dis 135, 729-735 (1977)
136. Sobel J. D., N. Hashman, G. Reinherz & D. Merzbach: Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med 73, 183-186 (1982)
137. Keizur J. J., B. Lavin & R. B. Leidich: Iatrogenic urinary tract infection with Pseudomonas cepacia after transrectal ultrasound guided needle biopsy of the prostate. J Urol 149, 523-526 (1993)
138. Weems J. J.: Nosocomial outbreak of Pseudomonas cepacia associated with contamination of reusable electronic ventilator temperature probes. Infect Control Hosp Epidemiol 14, 583-586 (1993)
139. Gravel-Tropper D., M. L. Sample, C. Oxley, B. Toye, D. E. Woods & G. E. Garber: Three-year outbreak of pseudobacteremia with Burkholderia cepacia traced to a contaminated blood gas analyzer. Infect Control Hosp Epidemiol 17, 737-740 (1996)
140. Reboli A. C., R. Koshinski, K. Arias, K. Marks-Austin, D. Stieritz & T. L. Stull: An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect Control Hosp Epidemiol 17, 741-743 (1996)
141. Matrician L., G. Ange, S. Burns, W. L. Fanning, C. Kioski, G. D. Cage & K. K. Komatsu: Outbreak of nosocomial Burkholderia cepacia infection and colonization associated with intrinsically contaminated mouthwash. Infect Control Hosp Epidemiol 21, 739-741 (2000)
142. Gravel D., M. L. Sample, K. Ramotar, B. Toye, C. Oxley & G. Garber: Outbreak of Burkholderia cepacia in the adult intensive care unit traced to contaminated indigo-carmine dye. Infect Control Hosp Epidemiol 23, 103-106 (2002)
143. Siddiqui A. H., M. E. Mulligan, E. Mahenthiralingam, J. Hebden, J. Brewink, S. Qaiyumi, J. A. Johnson & J. J. LiPuma: An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Infect Control Hosp Epidemiol 22, 419-422 (2001)
144. Berkelman R. L., S. Lewin, J. R. Allen, R. L. Anderson, L. D. Budnick, S. Shapiro, S. M. Friedman, P. Nicholas, R. S. Holzman & R. W. Haley: Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med 95, 32-36 (1981)
145. Craven D. E., B. Moody, M. G. Connolly, N. R. Kollisch, K. D. Stottmeier & W. R. McCabe: Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med 305, 621-623 (1981)
146. Ledson M. J., M. J. Gallagher & M. J. Walshaw: Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax 53, 430-432 (1998)
147. Holmes A., R. Nolan, R. Taylor, R. Finley, M. Riley, R. Jiang, S. Steinbach, & R. Goldstein. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 179, 1197-1205 (1997)
148. Palleroni N. J.: Genus I Pseudomonas Migula 1894, 237AL. In: Bergey's Manual of Systematic Bacteriology Volume 1. Eds: Krieg NR, Holt JG, Williams and Wilkins, Baltimore, MD (1984)
149. Christenson J. C., D. F. Welch, G. Mukwaya, M. J. Muszynsky, R. E. Weaver & D. J. Brenner: Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol 27, 270-273 (1989)
150. Ross J. P., S. M. Holland, V. J. Gill, E. S. DeCarlo & J. I. Gallin: Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases. Clin Infect Dis 21, 1291-1293 (1995)
151. Hoare S. & A. J. Cant: Chronic granulomatous disease presenting as severe sepsis due to Burkholderia gladioli. Clin Infect Dis 23, 441 (1996)
152. Khan S. U., S. M. Gordon, P. C. Stilwell, T. J. Kirby & A. C. Arroliga: Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation. Pediatr Infect Dis J 15, 637-639 (1996)
153. Graves M., T. Robin, A. M. Chipman, J. Wong, S. Khashe & J. M. Janda: Four additional cases of Burkholderia gladioli infection with microbiological correlates and review. Clin Infect Dis 25, 838-842 (1997)
154. Jones A. M., T. N. Stanbridge, B. J. Isalska, M. E. Dodd & A. K. Webb: Burkholderia gladioli: recurrent abscesses in patient with cystic fibrosis. J Infect 42, 69-71 (2001)
155. Shelly D. B., T. Spilker, E. Gracely, T. Coenye, P. Vandamme & J. J. LiPuma: Utility of commercial test systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J Clin Microbiol 38, 3112-3115 (2000)
156. Wilsher M. L., J. Kolbe, A. J. Morris & D. F. Welch. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med 155, 1436-1440 (1997)
157. Clode F. E., L. A. Metherell & T. L. Pitt. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med 160, 374-375 (1999)
158. Whitby P. W., L. C. Pope, K. B. Carter, J. J. LiPuma & T. L. Stull: Species-specific PCR as a tool for the identification of Burkholderia gladioli. J Clin Microbiol 38, 282-285 (2000)
159. Centers for Disease Control and Prevention: Laboratory-acquired human glanders - Maryland, May 2000. MMWR 49, 532-535 (2000)
160. Wheelis M.: First shots fired in biological warfare. Nature 395, 213 (1998)
161. Gilligan P.: Pseudomonas and Burkholderia. In: Manual of Clinical Microbiology. Eds.: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, ASM Press, Washington DC (1995)
162. Dance D. A.: Melioidosis: the tip of the iceberg? Clin Microbiol Rev 4, 52-60 (1991)
163. Dance D. A.: Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 74, 159-168 (2000)
164. Haase A., H. Smith-Vaughan, A. Melder, Y. Wood, A. Janmaat, J. Gilfedder, D. Kemp & B. Currie: Subdivision of Burkholderia pseudomallei ribotypes into multiple types by random amplified polymorphic DNA analysis provides new insights into epidemiology. J Clin Microbiol 33, 1687-1690 (1995)
165. Currie B. J., M. Mayo, N. M. Anstey, P. Donohoe, A. Haase & D. J. Kemp: A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates. Am J Trop Med Hyg 65, 177-179 (2001)
166. Currie B. J., D. A. Fisher, D. M. Howard, J. N. Burrow, S. Selvanayagam, P. L. Snelling, N. M. Anstey & M. J. Mayo: The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 74, 121-127 (2000)
167. Dorman S. E., V. J. Gill, J. I. Gallin & S. M. Holland: Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin Infect Dis 26, 889-894 (1998)
168. Dance D. A., M. D. Smith, H. M. Aucken & T. L. Pitt: Imported melioidosis in England and Wales. Lancet 353, 208 (1999)
169. Visca P., G. Cazzola, A. Petrucca & V. Vraggion: Travel-associated Burkholderia pseudomallei infection (melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis 32, e15-e16 (2001)
170. Schulin T. & I. Steinmetz: Chronic melioidosis in a patient with cystic fibrosis. J Clin Microbiol 39, 1676-1677 (2001)
171. McMenamin J. D., T. M. Zaccone, T. Coenye, P. Vandamme & J. J. LiPuma. Misidentification of Burkholderia cepacia in U.S. cystic fibrosis treatment centers: An analysis of 1051 recent sputum isolates. Chest 117,1661-1665 (2000).
172. Mahenthiralingam E., J. Bischof, S. K. Byrne, C. Radomski, J. E. Davies, Y Av-Gay & P. Vandamme. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 38,3165-3173 (2000)
173. Whitby P. W., K. B. Carter, J. L. Burns, J. A. Royall, J. J. LiPuma & T. L. Stull. Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR. J Clin Microbiol 38,4305-4309 (2000)
174. Coenye T, L. Liu, P. Vandamme & J. J. LiPuma. Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays. J Clin Microbiol 39,4452-4455 (2001)
175. Liu L., T. Coenye, J. L. Burns, P. Whitby, T. L. Stull & J. J. LiPuma. Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J Clin Microbiol 40,1210-1213 (2002)
176. Coenye T, P. Vandamme & LiPuma JJ. Infection by Ralstonia species in cystic fibrosis patients: Identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis 8,692-696 (2002)